Please login to the form below

Not currently logged in
Email:
Password:

Trump

This page shows the latest Trump news and features for those working in and with pharma, biotech and healthcare.

Not another thought leadership article… sorting the wheat from the chaff

Not another thought leadership article… sorting the wheat from the chaff

There is simply too much content to consume. In the study, nearly 40% of respondents agreed, so surely we should take that as a mandate that quantity no longer trumps quality.

Latest news

More from news
Approximately 45 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    Driving implementation isn’t easy, irrespective of NICE directives; the NHS moves slowly, and local factors will invariably trump national mandates.

  • Eliminating pharmaceutical rebates, is this déjà vu? Eliminating pharmaceutical rebates, is this déjà vu?

    In July 2020, the Trump administration announced its intention, for the second time, to prohibit rebates for Medicare Part D drugs within PBMs as one of several new Executive Orders aimed

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    In the early days of the Trump administration, then-FDA commissioner Scott Gottlieb made a point of clearing the way for even faster and more generic approvals, again with some apparent

More from intelligence
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...